The report
provides an estimation of 2013 opioid revenues and forecast consumption and
revenues until 2023 in the five major Western European countries: the UK,
Germany, France, Italy and Spain. The estimated revenues for 2013 are highest
in the UK, which held a share of 52%, followed by Germany with 20%. Spain had
the lowest in terms of both consumption (3.3%) and revenues (2.2%).
Their use
for medicinal purposes has been highly controversial for several decades.
Although recognized as potent painkillers, potential for misuse is high. As a
result, all regulatory authorities strive to maintain a fine balance between
enforcing strict regulations that will crack down on illicit usage but at the
same time ensure accessibility for genuine medical purposes. Amidst concerns
regarding inadequate pain management due to low accessibility, there are also
concerns regarding a lack of significant clinical evidence of their role in
managing chronic pain.
View Full Report with TOC @ http://www.radiantinsights.com/research/opioids-market-overview-to-2023-opioids-in-western-europe
However,
new abuse-deterrent technologies provide an incentive to prescribe more opioids
in pain management by alleviating concerns over misuse potential. The approval
of such new drugs and formulations has proved a new impetus to growth in opioid
usage in the five major Western European countries.
Opioids
are largely used for two medicinal purposes: pain management and substitution
treatment for drug dependence. Several of the recently approved and pipeline
opioid analgesics have a strong focus on reducing misuse potential, which is
one of the most significant barriers to usage in pain management. However,
usage is on the rise following the introduction of new abuse-deterrent
formulations of fentanyl and oxycodone, and initiatives that aim to rationalize
usage in pain management.
Demand is
also high in substitution treatment. While both methadone and buprenorphine are
approved for substitute treatment, buprenorphine usage increased in Europe
after the approval of Suboxone in 2006, in combination with naloxone, a pure
opioid antagonist that acts as an abuse-deterrent.
Scope
The report
covers the five major Western European countries (the UK, Germany, France,
Italy and Spain) and includes -
- An
overview of opioids in pain management and substitution treatment, and usage
constraints for both
- Brief analysis
of recent approvals of key abuse-deterrent drugs and their impact on
consumption and market growth
- Country
snapshots, comprising key regulations, consumption, market revenues, market
forecasts and key drivers and barriers
- An
overview of new abuse-deterrent technologies and profiles of key pipeline
products
Key
Reasons to Purchase
- Gain a
perspective of the opioids market size and key drivers and challenges that
dictate the market trends in each of the five major countries in Western Europe
- Gauge
the impact of key recently approved abuse-deterrent technologies on opioid
usage
- Develop
an understanding of how the regulatory landscape affects market potential and
growth in each country
- Identify
the key molecules that are currently the leading players in each region and
those that hold the highest potential in the forecast period
- Scan the
pipeline for innovative products with abuse-deterrent technologies that could
have an impact on opioid usage in the pain management market
About
Us
Radiant Insights is a platform
for companies looking to meet their market research and business intelligence
requirements. We assist and facilitate organizations and individuals procure
market research reports, helping them in the decision making process. We have a
comprehensive collection of reports, covering over 40 key industries and a host
of micro markets. In addition to over extensive database of reports, our
experienced research coordinators also offer a host of ancillary services such
as, research partnerships/ tie-ups and customized research solutions.
For
more information visit: Radiant
Insights
Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
Blog URL: http://radiantinsights.weebly.com/
No comments:
Post a Comment